You may qualify if a doctor prescribed Suboxone film for opioid-use disorder or pain and you later developed severe decay, cavities, broken teeth, tooth loss or extractions during or after use. Suboxone is a buprenorphine medicine that dissolves in the mouth, and the claims focus on that dissolvable film form. These are not automatic payout claims. Federal film cases move as individual lawsuits through coordinated pretrial proceedings, so eligibility turns on your prescription, dental injury and filing deadline.
Official resources:
- Read the original research from NIH — Use this page to review the original research.
- Read the official guidance from FDA — Use this primary source to verify the official guidance.
Table of Contents
- Which dental injuries fit the claim pattern?
- What proof do case reviews usually require?
- Why is the focus on dissolvable film?
- Where do federal cases stand?
- How can you check your eligibility?
Which dental injuries fit the claim pattern?
The pattern centers on severe harm after film use. It includes serious tooth decay, cavities, broken teeth, tooth loss and extractions that appeared during or after treatment.
Lawsuits point to the mouth-dissolving exposure as the link. The U.S. Food and Drug Administration said in its January 2022 drug safety warning that buprenorphine medicines dissolved in the mouth can cause serious decay, cavities, oral infections and tooth loss, even with no prior dental history.
What proof do case reviews usually require?
Firms generally look for a clear prescription-to-injury sequence. They also check whether you received an adequate warning and whether your state deadline still allows filing, as described in a 2026 eligibility guide from TorHoerman Law.
Missing records do not always end review. Pharmacy printouts, dentist notes and extraction reports often fill gaps.
- Pharmacy or medical records showing Suboxone film use for opioid-use disorder or pain
- Dental records showing severe decay, cavities, broken teeth, tooth loss or extractions
- A timeline linking the dental harm to periods during or after film use
- Evidence you lacked adequate warning before the 2022 label change
- Filing within your state statute of limitations
Why is the focus on dissolvable film?
The FDA required a new label warning for dental harm after reviewing reports tied to products dissolved in the mouth. That warning history matters because many claims involve use before patients saw updated risk language. DrugWatch reports that the lawsuits allege Indivior knew or should have known about the film risk but failed to warn patients and prescribers before the 2022 label change, according to its Suboxone lawsuit page.
The core question is warning timing, not whether opioids carry other risks. This also explains why tablets or strips dissolved orally draw more scrutiny. Other delivery forms do not present the same direct tooth-surface contact described in the warning.
Where do federal cases stand?
Federal film cases were centralized for coordinated pretrial work. The Judicial Panel on Multidistrict Litigation centralized them as MDL 3092 in the Northern District of Ohio before Judge J. Philip Calabrese, according to the transfer order.
The docket remains active. JPML statistics list 2,022 pending actions in MDL 3092 as of Oct. 1, 2026. There is no certified class, no liability finding and no global settlement, so consumers cannot join a fund automatically.
How can you check your eligibility?
Start with dates and documents. Pull your Suboxone prescription history, list every dentist and oral surgeon you saw, and request treatment notes, X-rays and extraction records.
Then map use against injury. Note when film treatment began, when pain or decay began, which teeth broke or were removed, and what warnings you recall from the label or prescriber. Bring that packet to a case review and ask about your state filing deadline first.